Product Theater: Clinical Data on Phexxi Vaginal Gel: Contraception and Beyond
Tuesday, November 17, 2020
7:30pm - 8:30pm Eastern Time via Webinar
Click here to join the webinar.
Unintended pregnancy rates remain high United States. With the recent approval of the nonhormonal vaginal pH modulator, Phexxi, there are now more contraceptive options than ever before. Join this product theatre to learn more about Phexxi, a nonhormonal vaginal ph modulator.
Topics discussed will include:
- Overview of the contraceptive landscape in the US
- Description of the Phase III study for Phexxi (AMPOWER)
- Efficacy and safety data from AMPOWER
- Brief overview of the EVO100 STI trial
Speaker: Brandi Howard, PhD, Head of Medical Affairs, Evofem Biosciences
In accordance with the Americans with Disabilities Act (ADA), the National Association of Nurse Practitioners in Women’s Health (NPWH) strives to provide reasonable accommodations and services for persons who require special assistance to participate in our events (virtual and in-person). We strive to host inclusive, accessible events that enable all individuals, including individuals with disabilities, to engage fully. Advance notice is necessary to arrange for some accessibility needs. To request an accommodation or for inquiries about accessibility, please contact Donna Ruth, email@example.com.